Webinars

Transparency-by-Design: Build Efficiencies into Your Clinical Document Disclosure Process

Join Abby McDonell, Sr. Program Manager with IQVIA’s Clinical Trial Transparency Team (powered by Privacy Analytics), to gain actionable insights on optimising your medical writing processes to ...

Linkage, Tokenization and De-identification

Watch this replay of our webinar to learn about tokenization and how it can be used to match individuals without exposing key identifiers, the risk of re-identification and how it can increase when ...

Everything You Need to Know About EMA Policy 0070 Right Now

On May 16, the European Medicines Agency (EMA) confirmed that after a long hiatus (punctuated only by COVID-related publications), Policy 0070 will officially resume in September 2023. Join Niamh ...

Safely Accelerate Clinical Document Submissions While Protecting Commercially Confidential Information (CCI)

As a clinical trial sponsor, you’re under tight timelines to balance participant privacy and data utility in clinical document submissions while justifying and protecting commercially sensitive ...

How to Protect Your Company’s Commercial Interest Under EU CTR

As a clinical trial sponsor, you’re under pressure to be transparent, but how do you ensure your clinical study documents don’t reveal confidential trade secrets when published by regulators?

3 Ways to Safely Accelerate Your Clinical Document Submissions

As a clinical trial sponsor, you were already facing tight timelines and resource constraints in handling regulatory requirements for document anonymization and redaction.

The CDO’s Actionable Framework to Share Sensitive Data

In this panel replay, you’ll get tangible strategies and tactics to identify, substantiate and communicate a compelling, urgent reason to provide internal access to sensitive data or to share ...

Shaping Strategy Through Trustworthy Data Sharing & Analytics

CDOs are increasingly becoming responsible for enterprise-wide governance and the use of information as an asset, as well as organizational data sharing & analytics strategy.

The Secret to Faster Clinical Document Submissions?

As a clinical trial sponsor, you were already facing tight timelines and resource constraints in handling regulatory requirements for document anonymization and redaction.

Driving Innovation with Best-of-Breed Data Masking Technology

Are you confident in the technology you’re using to protect the privacy of people represented in the sensitive data your organization handles every day?

Unleashing the Power of Clinical Trial Data

Data and transparency leaders in the pharma industry are increasingly embracing the digital shift toward reusing clinical trial data for new benefits, including future trial design. Watch our webinar ...

Safely Innovating with Sensitive Data: How Comcast and Nuance Drive Value & Protect Privacy

Your organization’s sensitive data is powerful. But failing to use it safely – or failing to use it at all – can lead to reputational damage and loss of trust. When leveraging data derived from ...

Introduction to Data Privacy

Data privacy, handled responsibly, is your unshakable bedrock for earning trust. That earned trust will allow you to innovate in ways that can benefit everyone.

Choose Your Own Data Sharing Strategy: Leadership Edition

In this choose your own data sharing adventure, leaders were asked to navigate and overcome several twists and turns – in real time – to meet business needs, while balancing internal resistance to ...

Developing a Data-Sharing Leadership Playbook

Watch this on-demand executive roundtable presented by MIT Chief Data Officer & Information Quality program and Privacy Analytics – featuring a dynamic discussion about safely sharing sensitive ...

Gain the confidence to safely use and share sensitive data (with our advisory services)

Your organization’s sensitive data is a powerful and valuable resource. But using it in a way that fails to protect individual privacy under regulations such as GDPR, HIPAA, and CCPA can lead to ...

Let's Talk Privacy, Interview with Luk Arbuckle

What are anonymization and de-identification? Do they mean the same thing? Is there even consensus about their meaning? Luk Arbuckle draws on his deep experience in anonymization to address these ...

3 Steps to a Safe Data Strategy

Strategy development can hold you back. You want to leverage your organization’s data assets, including those containing sensitive information, but you can’t get consensus on how to…

Be a Change Agent, Not a Secret Agent

As the healthcare industry evolves into an ecosystem of data-rich, digitally enabled stakeholders, drug manufacturers are losing their informational advantage in the value chain.

Privacy, Mobility, & Policy: Understanding Re-identification Risks in Mobility Data

Questions of how re-identifiable mobility data is—and whether individual location traces can be sufficiently anonymized—have become increasingly prominent as governments around the world seek to ...

MIT CDOIQ Symposium Panel Session - Safely Turn Sensitive Data into Business Opportunity

How can companies leverage the increasing business value of the sensitive data they manage (without running afoul of statutory regulations, or stakeholder trust)?

Earning Trust to Innovate with Sensitive Data

This is a co-presentation by global authorities in data and privacy, ending with a thorough, facilitated Q&A session. In the presentation, our experts share specific data privacy strategies and ...

A Roadmap to Understanding Data Potential

Before CDOs can unlock data value, they must first understand data potential. Although many CDOs today are deep into analytics, it can be challenging to determine which data assets hold the most ...

Stories from Real Life Data Privacy Heroes – Erin Rebholz, McKesson

Four data analytics and privacy leaders share the story of their respective journeys to either safely turn personal data into business value or earn trust by protecting the privacy of the people ...

Stories from Real Life Data Privacy Heroes – Doina Iepuras, Comcast

California’s Consumer Privacy Act inspired Comcast to evolve the way in which the company protects the privacy of customers who consent to share personal information with them. Doina Iepuras, Senior ...

Stories from Real Life Data Privacy Heroes – Tyler Schnoebelen, integrate.ai

Four data analytics and privacy leaders share the story of their respective journeys to either safely turn personal data into business value or earn trust by protecting the privacy of the people ...

Stories from Real Life Data Privacy Heroes – Rob Elliot, Novartis

Four data analytics and privacy leaders share the story of their respective journeys to either safely turn personal data into business value or earn trust by protecting the privacy of the people ...

Linklaters Webinar: Anonymization, pseudonymisation and the Five Safes

Luk Arbuckle, Chief Methodologist at Privacy Analytics, headquartered in Ottawa, Canada presents extracts from the new white paper: The Five Safes of Risk-Based Anonymization, co-authored with ...

Escape from the Data Swamp

Data velocity and privacy concerns are colliding. Data lakes are turning into data swamps. View our webcast with world-renowned data gurus Jules Polonetsky and Luk Arbuckle.

Good Is Not Good Enough: A Conversation With Global Data Privacy Expert Dr. Ann Cavoukian

In this webinar, global data privacy expert Dr. Ann Cavoukian; and Luk Arbuckle, Chief Methodologist, Privacy Analytics Inc.; examine the controversies and challenges that compel organizations to ...

Filter by Data Type

Categories